The information in this site is intended for consultants, institutional investors and trustees only.

The information contained in these pages must not be used or relied upon by private investors. We recommend that you read our 'Terms & Conditions' before browsing the site.

Please click submit to confirm that you are a consultant, institutional investor or trustee and wish to continue.


Reintroducing securitisations to insurance portfolios


In January 2019, regulations were introduced to help revive European ABS issuance via a new Simple, Transparent & Standardised (STS) framework. This significantly reduces capital charges for insurers to hold high-quality ABS compared to previous requirements under Solvency II.

  • The following paper looks to explore how insurers can introduce eligible securitisations to their investment portfolios.
  • European ABS has a strong multi-decade track record of low default rates, while often providing a spread over other fixed income securities.
  • STS eligibility is not restricted to new issues, which opens up a sizeable investment universe for potential portfolio diversification.

Read more

Please remember that past performance is not a guide to future performance.

The value of investments will fluctuate, which will cause prices to fall as well as rise and investors may not get back the original amount they invested.

For institutional investors only. Not for onward distribution to any other type of client. No other persons should rely on the information contained on this website.